Optimization and evaluation of a thermoresponsive ophthalmic in situ gel containing curcumin-loaded albumin nanoparticles

International Journal of Nanomedicine

Volumn 9, Issue 1, 2014, Pages 2517-2525

  Lou, Jie ^a   Hu, Wenjing ^b   Tian, Rui ^a   Zhang, Hua ^a   Jia, Yuntao ^c   Zhang, Jingqing ^a   Zhang, Liangke ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

^b Department of Function Examination   (China)

^c CHILDREN S HOSPITAL OF CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Desolvation method; Diabetic retinopathy; Ocular drug delivery; Sustained release

Indexed keywords

ALBUMIN NANOPARTICLE; CURCUMIN; NANOPARTICLE; UNCLASSIFIED DRUG; DELAYED RELEASE FORMULATION; EXCIPIENT; EYE DROPS; NANOCAPSULE; NONSTEROID ANTIINFLAMMATORY AGENT; POLOXAMER; SERUM ALBUMIN;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AQUEOUS HUMOR; ARTICLE; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG EFFECT; DRUG EFFICACY; DRUG FORMULATION; EYE IRRITATION; FEMALE; GEL; IN VITRO STUDY; IN VIVO STUDY; MALE; NONHUMAN; OPHTHALMIC DRUG DELIVERY SYSTEM; PHASE TRANSITION; PROCESS OPTIMIZATION; RABBIT; SUSTAINED DRUG RELEASE; SUSTAINED RELEASE FORMULATION; TEMPERATURE SENSITIVITY; VISCOSITY; ADMINISTRATION AND DOSAGE; ANIMAL; CHEMICALLY INDUCED; CHEMISTRY; DELAYED RELEASE FORMULATION; DIFFUSION; ENDOPHTHALMITIS; HEAT; LACRIMAL FLUID; THERAPEUTIC USE; TOXICITY;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; AQUEOUS HUMOR; CURCUMIN; DELAYED-ACTION PREPARATIONS; DIFFUSION; ENDOPHTHALMITIS; EXCIPIENTS; FEMALE; HOT TEMPERATURE; MALE; NANOCAPSULES; OPHTHALMIC SOLUTIONS; POLOXAMER; RABBITS; SERUM ALBUMIN; TEARS;

EID: 84901324196     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S60270     Document Type: Article

References (35)

1. Alghadyan AA. Diabetic retinopathy-an update. Saudi J Ophthalmol. 2011;25(2):99-111.
2. Sivaprasad S, Gupta B, Crosby-Nwaobi R, Evans J. Prevalence of diabetic retinopathy in various ethnic groups: a worldwide perspective. Surv Ophthalmol. 2012;57(4):347-370.
3. Ola MS, Nawaz MI, Siddiquei MM, Al-Amro S, Abu El-Asrar AM. Recent advances in understanding the biochemical and molecular mechanism of diabetic retinopathy. J Diabetes Complications. 2012;26(1):56-64.
4. Agrawal SS, Naqvi S, Gupta SK, Srivastava S. Prevention and management of diabetic retinopathy in STZ diabetic rats by Tinospora cordifolia and its molecular mechanisms. Food Chem Toxicol. 2012;50(9):3126-3132.
5. Bartlett HE, Eperjesi F. Nutritional supplementation for type 2 diabetes: a systematic review. Ophthalmic Physiol Opt. 2008;28(6):503-523.
6. Grant MB, Davis MI, Caballero S, Feoktistov I, Biaggioni I, Belardinelli L. Proliferation, migration, and ERK activation in human retinal endothelial cells through A(2B) adenosine receptor stimulation. Invest Ophthalmol Vis Sci. 2001;42(9):2068-2073.
7. Pai A, El Shafei MM, Mohammed OAZ, Al Hashimi M. Current concepts in intravitreal drug therapy for diabetic retinopathy. Saudi J Ophthalmol. 2010;24(4):143-149.
8. Maia OO Jr, Takahashi BS, Costa RA, Scott IU, Takahashi WY. Combined laser and intravitreal triamcinolone for proliferative diabetic retinopathy and macular edema: one-year results of a randomized clinical trial. Am J Ophthalmol. 2009;147(2):291-297. e2.
9. Choi KS, Chung JK, Lim SH. Laser photocoagulation combined with intravitreal triamcinolone acetonide injection in proliferative diabetic retinopathy with macular edema. Korean J Ophthalmol. 2007;21(1):11-17.
10. Mosieniak G, Adamowicz M, Alster O, et al. Curcumin induces permanent growth arrest of human colon cancer cells: link between senescence and autophagy. Mech Ageing Dev. 2012;133(6):444-455.
11. Oh SW, Cha JY, Jung JE, et al. Curcumin attenuates allergic airway inflammation and hyper-responsiveness in mice through NF-kappaB inhibition. J Ethnopharmacol. 2011;136(3):414-421.
12. Molina-Jijon E, Tapia E, Zazueta C, et al. Curcumin prevents Cr(VI)-induced renal oxidant damage by a mitochondrial pathway. Free Radic Biol Med. 2011;51(8):1543-1557.
13. Wahl H, Tan L, Griffith K, Choi M, Liu JR. Curcumin enhances Apo2L/TRAIL-induced apoptosis in chemoresistant ovarian cancer cells. Gynecol Oncol. 2007;105(1):104-112.
14. Hu YH, Huang XR, Qi MX, Hou BY. Curcumin inhibits proliferation of human lens epithelial cells: a proteomic analysis. J Zhejiang Univ Sci B. 2012;13(5):402-407.
15. Burugula B, Ganesh BS, Chintala SK. Curcumin attenuates staurosporine-mediated death of retinal ganglion cells. Invest Ophth Vis Sci. 2011;52(7):4263-4273.
16. Ritch R. Natural compounds: evidence for a protective role in eye disease. Can J Ophthalmol. 2007;42(3):425-438.
17. Zhao D, Zhao X, Zu Y, et al. Preparation, characterization, and in vitro targeted delivery of folate-decorated paclitaxel-loaded bovine serum albumin nanoparticles. Int J Nanomedicine. 2010;5:669-677.
18. Miele E, Spinelli GP, Miele E, Tomao F, Tomao S. Albumin-bound formulation of paclitaxel (Abraxane ABI-007) in the treatment of breast cancer. Int J Nanomedicine. 2009;4:99-105.
19. Zhang L, Hou S, Mao S, Wei D, Song X, Lu Y. Uptake of folate-conjugated albumin nanoparticles to the SKOV3 cells. Int J Pharm. 2004;287(1-2):155-162.
20. Zu Y, Zhang Y, Zhao X, Zhang Q, Liu Y, Jiang R. Optimization of the preparation process of vinblastine sulfate (VBLS)-loaded folate-conjugated bovine serum albumin (BSA) nanoparticles for tumor-targeted drug delivery using response surface methodology (RSM). Int J Nanomedicine. 2009;4:321-333.
21. Nanjawade BK, Manvi FV, Manjappa AS. In situ-forming hydrogels for sustained ophthalmic drug delivery. J Control Release. 2007;122(2):119-134.
22. Hsiue GH, Chang RW, Wang CH, Lee SH. Development of in situ thermosensitive drug vehicles for glaucoma therapy. Biomaterials. 2003;24(13):2423-2430.
23. Asasutjarit R, Thanasanchokpibull S, Fuongfuchat A, Veeranondha S. Optimization and evaluation of thermoresponsive diclofenac sodium ophthalmic in situ gels. Int J Pharm. 2011;411(1-2):128-35.
24. Jeong B, Kim SW, Bae YH. Thermosensitive sol-gel reversible hydrogels. Adv Drug Deliv Rev. 2002;54(1):37-51.
25. Nie S, Hsiao WL, Pan W, Yang Z. Thermoreversible Pluronic F127-based hydrogel containing liposomes for the controlled delivery of paclitaxel: in vitro drug release, cell cytotoxicity, and uptake studies. Int J Nanomedicine. 2011;6:151-166.
26. Kim EY, Gao ZG, Park JS, Li H, Han K. rhEGF/HP-beta-CD complex in poloxamer gel for ophthalmic delivery. Int J Pharm. 2002;233(1-2):159-167.
27. Ma WD, Xu H, Wang C, Nie SF, Pan WS. Pluronic F127-g-poly(acrylic acid) copolymers as in situ gelling vehicle for ophthalmic drug delivery system. Int J Pharm. 2008;350(1-2):247-256.
28. El-Kamel AH. In vitro and in vivo evaluation of Pluronic F127-based ocular delivery system for timolol maleate. Int J Pharm. 2002;241(1):47-55.
29. Chopra S, Motwani SK, Iqbal Z, Talegaonkar S, Ahmad FJ, Khar RK. Optimisation of polyherbal gels for vaginal drug delivery by Box-Behnken statistical design. Eur J Pharm Biopharm. 2007;67(1):120-131.
30. Wei G, Xu H, Ding PT, Li SM, Zheng JM. Thermosetting gels with modulated gelation temperature for ophthalmic use: the rheological and gamma scintigraphic studies. J Control Release. 2002;83(1):65-74.
31. Abashzadeh S, Dinarvand R, Sharifzadeh M, Hassanzadeh G, Amini M, Atyabi F. Formulation and evaluation of an in situ gel forming system for controlled delivery of triptorelin acetate. Eur J Pharm Sci. 2011;44(4):514-521.
32. Giovagnoli S, Tsai T, DeLuca PP. Formulation and release behavior of doxycycline-alginate hydrogel microparticles embedded into Pluronic F127 thermogels as a potential new vehicle for doxycycline intradermal sustained delivery. AAPS Pharm Sci Tech. 2010;11(1):212-220.
33. Bozdag S, Gumus K, Gumus O, Unlu N. Formulation and in vitro evaluation of cysteamine hydrochloride viscous solutions for the treatment of corneal cystinosis. Eur J Pharm Biopharm. 2008;70(1):260-269.
34. Song Z, Feng R, Sun M, et al. Curcumin-loaded PLGA-PEG-PLGA triblock copolymeric micelles: preparation, pharmacokinetics and distribution in vivo. J Colloid Interface Sci. 2011;354(1):116-123.
35. Klouda L, Mikos AG. Thermoresponsive hydrogels in biomedical applications. Eur J Pharm Biopharm. 2008;68(1):34-45.